Diplomat Pharmacy (DPLO) : 15 days before expiry, shorts in Diplomat Pharmacy (DPLO) have reduced from 8,608,617 on Jul 29, 2016, to 8,088,992 on August 15, 2016. On an average, 533,310 shares are traded on the exchange. The outstanding bearish positions are equal to 18.6% of the float. Short sellers have covered -519,625 shares, a reduction of -6%, which underlines that they dont expect the stock to fall further from the current levels. The short interest information was released on Wednesday Aug 24th after the market close.
Diplomat Pharmacy (NYSE:DPLO): The stock opened at $33.41 on Wednesday but the bulls could not build on the opening and the stock topped out at $34.25 for the day. The stock traded down to $33.17 during the day, due to lack of any buying support eventually closed down at $33.32 with a loss of -0.60% for the day. The stock had closed at $33.52 on the previous day. The total traded volume was 497,245 shares.
In a related news, The Securities and Exchange Commission has divulged that Kaddis Atheer A, officer (EVP of Sales & Strategic Align) of Diplomat Pharmacy, Inc., had unloaded 12,325 shares at an average price of $35.88 in a transaction dated on August 1, 2016. The total value of the transaction was worth $442,221.
Diplomat Pharmacy, Inc. (Diplomat) is an independent specialty pharmacy in the United States. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers services in Specialty Drug Dispensing, which includes its specialty infusion pharmacy services. The specialty drug dispensing services include Patient Care Coordination, Clinical Services, Compliance and Persistency Programs, Patient Financial Assistance, Specialty Pharmacy Training/Consulting (Diplomat University), Benefits Investigation, Prior Authorization, Risk Evaluation and Medication Strategy (REMS), Retail Specialty Services, Hospital and Health System Services and Hub Services. The Company help patients adhere to complicated medication therapies, process refills and manage any side effects and insurance concerns to ensure they get the standard of care.